Stock Analysis

3 KRX Growth Companies With High Insider Ownership Expecting Up To 64% Revenue Growth

Published

In the last week, the South Korean market has stayed flat, with notable gains in the Healthcare sector at 5.6%. Despite this overall stability, earnings are forecast to grow by 29% annually, making growth companies with high insider ownership particularly attractive for investors seeking strong revenue potential.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.4%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.5%52.1%
Bioneer (KOSDAQ:A064550)15.8%97.6%
Oscotec (KOSDAQ:A039200)26.3%122%
Vuno (KOSDAQ:A338220)19.5%110.9%
HANA Micron (KOSDAQ:A067310)18.3%100.3%
Park Systems (KOSDAQ:A140860)33%35.7%
INTEKPLUS (KOSDAQ:A064290)16.3%96.7%
UTI (KOSDAQ:A179900)33.1%134.6%
Techwing (KOSDAQ:A089030)18.7%83.6%

Click here to see the full list of 89 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc., a bio company with a market cap of ₩18.75 trillion, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Operations: The company's revenue segment primarily comprises biotechnology, generating ₩90.79 billion.

Insider Ownership: 26.6%

Revenue Growth Forecast: 64.2% p.a.

ALTEOGEN, a South Korean biopharmaceutical company, recently received MFDS approval for Tergase®, a high-purity recombinant hyaluronidase. This milestone positions the company as it transitions to commercialization. With earnings forecasted to grow 99.46% annually and revenue expected to increase by 64.2% per year, ALTEOGEN is projected to become profitable in three years with high insider ownership and no recent substantial insider selling. However, shareholders experienced dilution over the past year.

KOSDAQ:A196170 Earnings and Revenue Growth as at Sep 2024

Enchem (KOSDAQ:A348370)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Enchem Co., Ltd. manufactures and sells electrolytes and additives for secondary batteries and EDLC, with a market cap of ₩4.17 trillion.

Operations: Enchem's revenue from electronic components and parts is ₩348.75 billion.

Insider Ownership: 19.4%

Revenue Growth Forecast: 63% p.a.

Enchem, a South Korean energy solutions provider, is forecasted to achieve significant revenue growth of 63% annually, outpacing the market. Earnings are expected to grow at 155.2% per year, with profitability anticipated within three years. Despite high insider ownership and no recent substantial insider trading activity, the company has experienced share price volatility and shareholder dilution over the past year.

KOSDAQ:A348370 Earnings and Revenue Growth as at Sep 2024

Hyosung Heavy Industries (KOSE:A298040)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Hyosung Heavy Industries Corporation manufactures and sells heavy electrical equipment in South Korea and internationally, with a market cap of ₩3.18 trillion.

Operations: The company's revenue is primarily derived from its Heavy Industry segment, which generated ₩3.35 trillion, and its Construction segment, which brought in ₩1.78 trillion.

Insider Ownership: 16.4%

Revenue Growth Forecast: 10.3% p.a.

Hyosung Heavy Industries, a South Korean industrial firm, is forecasted to achieve significant annual earnings growth of 35.33%, outpacing the market's 29%. Despite trading at 58.7% below its estimated fair value and high insider ownership, revenue growth is expected to be slower than the market at 10.3% per year. The company’s Return on Equity is projected to reach a strong 20.4% in three years, although it faces challenges with high debt not well covered by operating cash flow and recent share price volatility.

KOSE:A298040 Ownership Breakdown as at Sep 2024

Seize The Opportunity

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com